Results 101 to 110 of about 235,727 (237)
Natural Products from Mexican Medicinal Plants as Promising Trypanocidal Drugs
ChemistrySelect, Volume 10, Issue 37, October 6, 2025.Chagas disease (American Trypanosomiasis) is caused by the protozoan Trypanosoma cruzi. Worldwide it is one of the seventeen neglected tropical diseases. There is a need of new drugs. This review assesses the literature (2012‐2024) of secondary metabolites isolated from Mexican plants active against this parasite.
Karla Daniela Rodríguez‐Hernández +2 more
wiley +1 more source
Lack of correlation for anti-β1 autoantibodies and cardioelectric disorders in chagas cardiomyopathy [PDF]
, 2023 Analia G. Paolucci +5 more
openalex +1 more source
Travel Medicine and Infectious DiseaseBackground: Chagas Disease (CD) can cause Chagas cardiomyopathy. The new coronavirus disease (COVID-19) also affects the cardiovascular system and may worsen Chagas cardiomyopathy.
Ariela Mota Ferreira +15 more
doaj +1 more source
Frontiers in Immunology, 2019 B-cells mediate humoral adaptive immune response via the production of antibodies and cytokines, and by inducing T-cell activation. These functions can be attributed to distinct B-cell subpopulations. Infection with Trypanosoma cruzi, the causative agent
Livia Silva Araújo Passos +15 more
doaj +1 more source
Pacing and Clinical Electrophysiology, Volume 48, Issue 10, Page 1157-1166, October 2025.Distribution of distinct topographies and their relationship with NYHA classes and therapies. Each of the 111 dots represents a distinct PVC topography recorded in the 12L‐AECGs. Black dots represent PVC associated with patients classified as NYHA class I, green dots with NYHA class II, and yellow dots with NYHA class III.
Carlos Arthur Hansel Diniz da Costa +7 more
wiley +1 more source
Trypanosoma Cruzi Lineages Shape Macrophage Cytokine Profiles in Single and Mixed Infections
Parasite Immunology, Volume 47, Issue 9, September 2025.ABSTRACT Chagas disease, caused by Trypanosoma cruzi, exhibits a wide clinical spectrum, which is influenced by the parasite's extensive genetic diversity. Growing evidence indicates that human infections are often multiclonal, involving a dynamic population of parasite clones, collectively termed the “cruziome”. The immunological consequences of these
Cecília Luiza Pereira +5 more
wiley +1 more source
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy: Clinical Practice Update
Journal of Education, Health and SportBackground: Chronic Chagas cardiomyopathy is an arrhythmogenic, fibrosis-prone form of heart failure that develops years after Trypanosoma cruzi infection. Standard therapy has largely been extrapolated from non-Chagas trials.
Katarzyna Skibicka +3 more
doaj +1 more source
Frontiers in Microbiology, 2018 Chagas cardiomyopathy is the most severe clinical manifestation of chronic Chagas disease. The disease affects most of the Latin American countries, being considered one of the leading causes of morbidity and death in the continent.
Leandra Linhares-Lacerda +14 more
doaj +1 more source
Frontiers in ImmunologyChagas cardiomyopathy is the most severe chronic manifestation and leading cause of mortality in the disease. Chronic inflammation, resulting from persistent infection by T.
Victor Vaitkevicius-Antão +11 more
doaj +1 more source
Ventricular arrhythmias in Chagas disease
Revista da Sociedade Brasileira de Medicina Tropical, 2015 Sudden death is one of the most characteristic phenomena of Chagas disease, and approximately one-third of infected patients develop life-threatening heart disease, including malignant ventricular arrhythmias.
Marco Paulo Tomaz Barbosa +3 more
doaj +1 more source